Form 8-K - Current report:
SEC Accession No. 0001367644-22-000105
Filing Date
2022-07-06
Accepted
2022-07-06 16:09:56
Documents
16
Period of Report
2022-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ebs-20220701.htm   iXBRL 8-K 38681
2 EX-99 a070622-boardappointssuj.htm EX-99 5670
7 GRAPHIC a070622-boardappointssuj001.jpg GRAPHIC 228167
8 GRAPHIC a070622-boardappointssuj002.jpg GRAPHIC 141381
  Complete submission text file 0001367644-22-000105.txt   710285

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20220701.xsd EX-101.SCH 2218
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20220701_def.xml EX-101.DEF 2933
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20220701_lab.xml EX-101.LAB 27198
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20220701_pre.xml EX-101.PRE 14705
10 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20220701_htm.xml XML 11009
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 221068771
SIC: 2834 Pharmaceutical Preparations